These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27885995)

  • 21. Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin.
    Charoenputtakun P; Li SK; Ngawhirunpat T
    Int J Pharm; 2015 Nov; 495(1):318-328. PubMed ID: 26325320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Needle-free transdermal delivery using PLGA nanoparticles: effect of particle size, injection pressure and syringe orifice diameter.
    Park CH; Tijing LD; Kim CS; Lee KM
    Colloids Surf B Biointerfaces; 2014 Nov; 123():710-5. PubMed ID: 25456991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
    Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
    Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
    Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
    J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study.
    Mohammed MI; Makky AM; Teaima MH; Abdellatif MM; Hamzawy MA; Khalil MA
    Drug Deliv; 2016 Jun; 23(5):1558-64. PubMed ID: 25726990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.
    Bae J; Park JW
    Int J Pharm; 2015 Mar; 480(1-2):37-47. PubMed ID: 25595570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
    Juluri A; Peddikotla P; Repka MA; Murthy SN
    J Pharm Sci; 2013 Feb; 102(2):500-7. PubMed ID: 23175436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
    Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
    J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLGA-based nanoparticles: effect of chitosan in the aggregate stabilization. A dielectric relaxation spectroscopy study.
    Chronopoulou L; Cutonilli A; Cametti C; Dentini M; Palocci C
    Colloids Surf B Biointerfaces; 2012 Sep; 97():117-23. PubMed ID: 22609591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
    He W; Horn SW; Hussain MD
    Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
    Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
    Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking.
    Lee PW; Hsu SH; Tsai JS; Chen FR; Huang PJ; Ke CJ; Liao ZX; Hsiao CW; Lin HJ; Sung HW
    Biomaterials; 2010 Mar; 31(8):2425-34. PubMed ID: 20034662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucosylated polymeric nanoparticles: a sweetened approach against blood compatibility paradox.
    Thasneem YM; Sajeesh S; Sharma CP
    Colloids Surf B Biointerfaces; 2013 Aug; 108():337-44. PubMed ID: 23563302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.
    Schaefers M; Muysers C; Alexandersen P; Christiansen C
    Menopause; 2009; 16(3):559-65. PubMed ID: 19423999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charged nanoparticles delivery to the eye using hydrogel iontophoresis.
    Eljarrat-Binstock E; Orucov F; Aldouby Y; Frucht-Pery J; Domb AJ
    J Control Release; 2008 Mar; 126(2):156-61. PubMed ID: 18201790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V; Sadoqi M; Shao J
    Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possibility for the development of cosmetics with PLGA nanospheres.
    Ito F; Takahashi T; Kanamura K; Kawakami H
    Drug Dev Ind Pharm; 2013 May; 39(5):752-61. PubMed ID: 22725249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
    Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
    Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles.
    Van de Ven H; Vermeersch M; Vandenbroucke RE; Matheeussen A; Apers S; Weyenberg W; De Smedt SC; Cos P; Maes L; Ludwig A
    J Drug Target; 2012 Feb; 20(2):142-54. PubMed ID: 22080813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.